Incipient Neurovulnerability and Neuroprotection in Early Psychosis
The DOI matches its Crossref record.
Abstract
The objective of this study was to review the implications of altered regulatory mechanisms of progenitor cell generation and death for neurodevelopment and adult brain functioning in early intervention in schizophrenia and related disorders. MEDLINE databases were searched from 1966 to 2002 using the following keywords: stem cells, progenitor cells, glia, neurogenesis, apoptosis, combined with brain and schizophrenia. Necropsy evidence suggests alterations in synaptic connectivity and a reduction in glial cell numbers with no substantial signs of neuronal cell loss or necrotic neurodegeneration (gliosis). Neuroimaging data propose dynamic structural changes with some evidence of volume loss of the hippocampus during the transition to psychosis. Central and peripheral tissues of patients with schizophrenia give indirect evidence of reduced neurotrophic and anti-apoptotic factors relevant for generation, and atrophic degeneration of cells of glial and, in some brain areas, even neuronal origin. In vivo brain magnetic resonance spectroscopy data in schizophrenia support the loss of neuropil (reduction in N-acetylaspartate) and increased membrane turnover (decrease in phosphomonoesters [PMEs], increase in phosphodiesterases [PDEs]) at the onset of illness, which potentially corresponds with increased apoptotic activity of progenitor cells. In conclusion, dysfunctional regulation of generation and degeneration of progenitor cells of glial and, in some brain areas, neuronal origin may potentially explain early and late neurodevelopmental abnormalities in early psychosis. A reduced genesis or an increased death of glial cells in the grey matter may provide the cellular substrate for synaptic and dendritic changes resulting in local atrophy and disconnectivity. Neuroprotective strategies counteracting the loss or supporting the generation of progenitor cells may therefore be a potent therapeutic avenue to explore. Psychopharmacology Bulletin. 2003;37(2):79-101.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pantelis, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi034 · Cited by 573
Declining Transition Rate in Ultra High Risk (Prodromal) Services: Dilution or Reduction of Risk?
Yung, A. R., Yuen, H. P., Berger, G., Francey, S., Hung, T.-C., Nelson, B., Phillips, L., & McGorry, P. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm015 · Cited by 416
Self-citationMcGorry, P. D., Yung, A. R., & Phillips, L. J. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007046 · Cited by 294
Apoptotic mechanisms and the synaptic pathology of schizophrenia
Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.014 · Cited by 292
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
Metadata
- Authors
- Berger, G. E., MD, (CH), F. P., Wood, S., (Cantab), M., PhD, McGorry, A. P. D., MBBS, MD, PhD, FRCP, & FRANZCP
- Venue
- Psychopharmacology Bulletin
- Publisher
- Medworks Media Inc.
- Published
- 2025-08-12
- Volume
- 37
- Issue
- 2
- Pages
- 79-101
- ISSN
- 0048-5764 (ISSN-L)
- 2472-2448
- OpenAlex
- W2992376260
- Cited by
- 82
- References
- 0
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incipient Neurovulnerability and Neuroprotection in Early Psychosis. https://app.cochat.ai/papers/10.64719/pb.4186
- The paper
- Berger, G. E., MD, (CH), F. P., Wood, S., (Cantab), M., PhD, McGorry, A. P. D., MBBS, MD, PhD, FRCP, & FRANZCP. (2025). Incipient Neurovulnerability and Neuroprotection in Early Psychosis. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.